ornithine has been researched along with Infarction, Middle Cerebral Artery in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askar, M; Barakat, W; El-Kannishy, S; Fahmy, A | 1 |
| Cao, L; Gao, Q; Jiang, T; Lu, J; Tan, L; Tan, MS; Wang, HF; Yu, JT; Zhang, QQ; Zhang, YD; Zhu, XC | 1 |
| Connell, B; Saleh, TM; Wilson, BC | 1 |
| Cheng, H; Fu, YT; Huang, SS; Hung, LM; Liu, HY; Nien, MW; Tsai, SK; Zhang, FB | 1 |
4 other study(ies) available for ornithine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Effectiveness of arginase inhibitors against experimentally induced stroke.
Topics: Animals; Arginase; Behavior, Animal; Blood-Brain Barrier; Citrulline; DNA, Complementary; Glycation End Products, Advanced; Infarction, Middle Cerebral Artery; Interleukin-1beta; Male; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ornithine; Rats, Wistar; Tumor Necrosis Factor-alpha | 2018 |
Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.
Topics: Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Animals; Brain; Cerebrovascular Circulation; Endostatins; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Ornithine; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2014 |
Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms.
Topics: Analysis of Variance; Animals; Brain Infarction; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Ornithine; Rats; Relaxin; Tetrazolium Salts | 2006 |
Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Ligation; Male; Malondialdehyde; Middle Cerebral Artery; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Rats; Rats, Long-Evans; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation | 2007 |